A review of the literature on the management of esophagogastric varices published in the last 12 months shows that the data are still quite conflicting. In the primary and secondary prophylaxis of variceal bleeding, β-blockers are still the mainstay of pharmacotherapy. Measurement of the hepatic portal venous pressure gradient is considered to be a reliable parameter for successful reduction of portal pressure using medical therapy. However, intolerance of propranolol requiring discontinuation of therapy has been observed in approximately 30 % of patients. Patients’ compliance with medication may represent another drawback of medical therapy. The role of endoscopic band ligation in secondary prophylaxis is now indisputable, especially in comparison with sclerotherapy. In the primary prevention of variceal bleeding, band ligation is beginning to have a competitive edge over pharmacological therapy. Acute variceal bleeding is no longer a frequent morbid emergency. Most cases of bleeding can now be managed successfully with band ligation and N-butyl-2-cyanoacrylate obliteration. N-butyl-2-cyanoacrylate has come into increasingly widespread use in the treatment of bleeding gastric fundal varices in which surgery or transjugular intrahepatic portosystemic shunting were previously regarded as the preferred therapies.
References
1
Ichikawa S, Okamura S, Tujigami K. et al .
Quantitative analysis of red color sign in the endoscopic evaluation of esophageal varices.
Endoscopy.
2001;
33
747-753
3
Lin H C, Yang Y Y, Hou M C. et al .
Hemodynamic effects of a combination of octreotide and terlipressin in patients with viral hepatitis related cirrhosis.
Scand J Gastroenterol.
2002;
37
482-487
4
Cales P, Masliah C, Bernard B. et al .
Early administration of vapreotide for variceal bleeding in patients with cirrhosis. French Club for the Study of Portal Hypertension.
N Engl J Med.
2001;
344
23-28
5
Gross M, Schiemann U, Muhlhofer A, Zoller W G.
Meta-analysis: efficacy of therapeutic regimens in ongoing variceal bleeding.
Endoscopy.
2001;
33
737-746
6
Lee M S, Cho J Y, Cheon Y K. et al .
Use of detachable snares and elastic bands for endoscopic control of bleeding from large gastric varices.
Gastrointest Endosc.
2002;
56
83-88
7
Kitamoto M, Imamura M, Kamada K. et al .
Balloon-occluded retrograde transvenous obliteration of gastric fundal varices with hemorrhage.
Am J Roentgenol.
2002;
178
1167-1174
8
Akahoshi T, Hashizume M, Shimabukuro R. et al .
Long-term results of endoscopic Histoacryl injection sclerotherapy for gastric variceal bleeding: a 10-year experience.
Surgery.
2002;
131
S176-181
9
Dhiman R K, Chawla Y, Taneja S. et al .
Endoscopic sclerotherapy of gastric variceal bleeding with N-butyl-2-cyanoacrylate.
J Clin Gastroenterol.
2002;
35
222-227
10
Sarin S K, Jain A K, Jain M, Gupta R.
A randomized controlled trial of cyanoacrylate versus alcohol injection in patients with isolated fundic varices.
Am J Gastroenterol.
2002;
97
1010-1015
11
Nguyen A J, Baron T H, Burgart L J. et al .
2-Octyl-cyanoacrylate (Dermabond), a new glue for variceal injection therapy: results of a preliminary animal study.
Gastrointest Endosc.
2002;
55
572-575
12
Heneghan M A, Byrne A, Harrison P M.
An open pilot study of the effects of a human fibrin glue for endoscopic treatment of patients with acute bleeding from gastric varices.
Gastrointest Endosc.
2002;
56
422-426
13
Laine L, Cook D.
Endoscopic ligation compared with sclerotherapy for treatment of esophageal variceal bleeding: a meta-analysis.
Ann Intern Med.
1995;
123
280-287
14
de la Pena J, Rivero M, Sanchez E. et al .
Variceal ligation compared with endoscopic sclerotherapy for variceal hemorrhage: prospective randomized trial.
Gastrointest Endosc.
1999;
49
417-423
15
Lopes C V, Pereira-Lima J C, Marroni C A.
Efficacy of endoscopic variceal band ligation according to Child-Pugh grade [abstract].
Gastrointest Endosc.
2001;
53
AB158
16
Orozco H, Mercado M A, Chan C. et al .
A comparative study of the elective treatment of variceal hemorrhage with beta-blockers, transendoscopic sclerotherapy, and surgery: a prospective, controlled, and randomized trial during 10 years.
Ann Surg.
2000;
232
216-219
17
Villanueva C, Minana J, Ortiz J. et al .
Endoscopic ligation compared with combined treatment with nadolol and isosorbide mononitrate to prevent recurrent variceal bleeding.
N Engl J Med.
2001;
345
647-655
18
Patch D, Sabin C A, Goulis J. et al .
A randomized, controlled trial of medical therapy versus endoscopic ligation for the prevention of variceal rebleeding in patients with cirrhosis.
Gastroenterology.
2002;
123
1013-1019
19
Lo G H, Chen W C, Chen M H. et al .
Banding ligation versus nadolol and isosorbide mononitrate for the prevention of esophageal variceal rebleeding.
Gastroenterology.
2002;
123
728-734
20
Chen W C, Hou M C, Lin H C. et al .
Feasibility and potential benefit of maintenance endoscopic variceal ligation in patients with unresectable hepatocellular carcinoma and acute esophageal variceal hemorrhage: a controlled trial.
Gastrointest Endosc.
2001;
54
18-23
21
Singh P, Pooran N, Indaram A, Bank S.
Combined ligation and sclerotherapy versus ligation alone for secondary prophylaxis of esophageal variceal bleeding: a meta-analysis.
Am J Gastroenterol.
2002;
97
623-629
22
Baroncini D, Milandri G L, Borioni D. et al .
A prospective randomized trial of sclerotherapy versus ligation in the elective treatment of bleeding esophageal varices.
Endoscopy.
1997;
29
235-240
23
Takase Y, Shibuya S, Chikamori F. et al .
Recurrence factors studied by percutaneous transhepatic portography before and after endoscopic sclerotherapy for esophageal varices.
Hepatology.
1990;
11
348-352
24
Al T raif, Fachartz F S, Al J umah. et al .
Randomized trial of ligation versus combined ligation and sclerotherapy for bleeding esophageal varices.
Gastrointest Endosc.
1999;
50
1-6
25
Lo G H, Lai K H, Cheng J S. et al .
The additive effect of sclerotherapy to patients receiving repeated endoscopic variceal ligation: a prospective, randomized trial.
Hepatology.
1998;
28
391-395
26
Polski J M, Brunt E M, Saeed Z A.
Chronology of histological changes after band ligation of esophageal varices in humans.
Endoscopy.
2001;
33
443-447
27
Nakamura S, Mitsunaga A, Murata Y. et al .
Endoscopic induction of mucosal fibrosis by argon plasma coagulation (APC) for esophageal varices: a prospective randomized trial of ligation plus APC vs. ligation alone.
Endoscopy.
2001;
33
210-215
28
Hino S, Kakutani H, Ikeda K. et al .
, et al. Low power diode laser treatment using indocyanine green for eradication of esophageal varices.
Endoscopy.
2001;
33
873-875
29
Lebrec D, Hillon P, Munoz C. et al .
The effect of propranolol on portal hypertension in patients with cirrhosis: a hemodynamic study.
Hepatology.
1982;
2
523-527
30
Abraczinskas D R, Ookubo R, Grace N D. et al .
Propranolol for the prevention of first esophageal variceal hemorrhage: a lifetime commitment?.
Hepatology.
2001;
34
1096-1102
31
González-Abraldes J, Albillos A, Banares R. et al .
Randomized comparison of long-term losartan versus propranolol in lowering portal pressure in cirrhosis.
Gastroenterology.
2001;
121
382-388
32
Schepke M, Werner E, Biecker E. et al .
Hemodynamic effects of the angiotensin II receptor antagonist irbesartan in patients with cirrhosis and portal hypertension.
Gastroenterology.
2001;
121
389-395
33
Lui H F, Stanley A J, Forrest E H. et al .
Primary prophylaxis of variceal hemorrhage: a randomized controlled trial comparing band ligation, propranolol, and isosorbide mononitrate.
Gastroenterology.
2002;
123
735-744
34
Irisawa A, Shibukawa G, Obara K. et al .
Collateral vessels around the esophageal wall in patients with portal hypertension: comparison of EUS imaging and microscopic findings at autopsy.
Gastrointest Endosc.
2002;
56
249-253
35
Konishi Y, Nakamura T, Kida H. et al .
Catheter US probe EUS evaluation of gastric cardia and perigastric vascular structures to predict esophageal variceal recurrence.
Gastrointest Endosc.
2002;
55
197-203
36
Hino S, Kakutani H, Ikeda K. et al .
Hemodynamic analysis of esophageal varices using color Doppler endoscopic ultrasonography to predict recurrence after endoscopic treatment.
Endoscopy.
2001;
33
869-872
37
Papatheodoridis G V, Goulis J, Leandro G. et al .
Transjugular intrahepatic portosystemic shunt compared with endoscopic treatment for prevention of variceal rebleeding: a meta-analysis.
Hepatology.
1999;
30
612-622
38
Luca A, D’Amico G, La G alla. et al .
TIPS for prevention of recurrent bleeding in patients with cirrhosis: meta-analysis of randomized clinical trials.
Radiology.
1999;
212
411-421
39
Pomier-Layrargues G, Villeneuve J P, Deschenes M. et al .
Transjugular intrahepatic portosystemic shunt (TIPS) versus endoscopic variceal ligation in the prevention of variceal rebleeding in patients with cirrhosis: a randomised trial.
Gut.
2001;
48
390-396
40
Sauer P, Hansmann J, Richter G M. et al .
Endoscopic variceal ligation plus propranolol vs. transjugular intrahepatic portosystemic stent shunt: a long-term randomized trial.
Endoscopy.
2002;
34
690-697
41
Gülberg V, Schepke M, Geigenberger G. et al .
Transjugular intrahepatic portosystemic shunting is not superior to endoscopic variceal band ligation for prevention of variceal rebleeding in cirrhotic patients: a randomized, controlled trial.
Scand J Gastroenterol.
2002;
37
338-343
42
Escorsell A, Banares R, Garcia-Pagan J C. et al .
TIPS versus drug therapy in preventing variceal rebleeding in advanced cirrhosis: a randomized controlled trial.
Hepatology.
2002;
35
385-392
43
Jalan R, Bzeizi K I, Tripathi D. et al .
Impact of transjugular intrahepatic portosystemic stent-shunt for secondary prophylaxis of oesophageal variceal haemorrhage: a single-centre study over an 11-year period.
Eur J Gastroenterol Hepatol.
2002;
14
615-626
44
Burroughs A K, Vangeli M.
Transjugular intrahepatic portosystemic shunt versus endoscopic therapy: randomized trials for secondary prophylaxis of variceal bleeding: an updated meta-analysis.
Scand J Gastroenterol.
2002;
37
249-252
45
Azoulay D, Castaing D, Majno P. et al .
Salvage transjugular intrahepatic portosystemic shunt for uncontrolled variceal bleeding in patients with decompensated cirrhosis.
J Hepatol.
2001;
35
590-597
46
Rössle M, Siegerstetter V, Olschewski M. et al .
How much reduction in portal pressure is necessary to prevent variceal rebleeding? A longitudinal study in 225 patients with transjugular intrahepatic portosystemic shunts.
Am J Gastroenterol.
2001;
96
3379-3383
47
Illuminati G, Smail A, Azoulay D. et al .
Association of transjugular intrahepatic portosystemic shunt with embolization in the treatment of bleeding duodenal varix refractory to sclerotherapy.
Dig Surg.
2000;
17
398-400
48
Chaves D M, Sakai P, Mucenic M. et al .
Comparative study of portal hypertensive gastropathy in schistosomiasis and hepatic cirrhosis.
Endoscopy.
2002;
34
199-202
49
Yeh J L, Peng Y C, Tung C F. et al .
Clinical predictors of large esophagogastric varices in patients with hepatocellular carcinoma.
Dig Dis Sci.
2002;
47
723-729
50
Okada K, Koda M, Murawaki Y, Kawasaki H.
Changes in esophageal variceal pressure after transcatheter arterial embolization for hepatocellular carcinoma.
Endoscopy.
2001;
33
595-600
